{"id":10061,"date":"2024-07-25T16:47:40","date_gmt":"2024-07-25T21:47:40","guid":{"rendered":"https:\/\/ibio.org\/?p=10061"},"modified":"2024-07-25T16:47:40","modified_gmt":"2024-07-25T21:47:40","slug":"endotronix-being-acquired-by-california-life-sciences-company-crains-chicago","status":"publish","type":"post","link":"https:\/\/ibio.org\/endotronix-being-acquired-by-california-life-sciences-company-crains-chicago\/","title":{"rendered":"Endotronix being acquired by California life sciences company – Crain\u2019s Chicago"},"content":{"rendered":"

Heart failure tech developer Endotronix is being acquired by Edwards Lifesciences a month after receiving regulatory approval for its implantable pulmonary artery sensor.<\/p>\n

Irvine, Calif.-based Edwards said in a press release it was exercising its option to acquire Naperville-based Endotronix following its initial investment in Endotronix’s 2016 Series C financing round.<\/p>\n

\u2026<\/p>\n

John Conrad, president and CEO of Illinois biotech association iBio, said the news was significant for Illinois.<\/p>\n

\u201cEndotronix\u2019s acquisition by Edwards Lifesciences is a remarkable success story for Illinois\u2019 life sciences ecosystem,” Conrad wrote in an iBio statement.<\/p>\n

“This acquisition not only validates the innovative spirit and technical expertise fostered in Illinois but also signals to the global health care community that our state is a fertile ground for groundbreaking medical technologies,” Conrad wrote. “Endotronix\u2019s journey showcases the potential for future growth in our biotech and medtech sectors, attracting more investment, talent, and opportunities to Illinois.”<\/p>\n

Read more on Crain\u2019s Chicago<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

Heart failure tech developer Endotronix is being acquired by Edwards Lifesciences a month after receiving regulatory approval for its implantable pulmonary artery sensor. Irvine, Calif.-based Edwards said in a press release it was exercising its option to acquire Naperville-based Endotronix following its initial investment in Endotronix’s 2016 Series C financing round. \u2026 John Conrad, president […]<\/p>\n","protected":false},"author":12,"featured_media":9943,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"categories":[477],"tags":[262,544,289],"class_list":["post-10061","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-ibio-in-the-news","tag-chicago","tag-edwards-life-sceinces","tag-endotronix"],"_links":{"self":[{"href":"https:\/\/ibio.org\/wp-json\/wp\/v2\/posts\/10061","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ibio.org\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ibio.org\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ibio.org\/wp-json\/wp\/v2\/users\/12"}],"replies":[{"embeddable":true,"href":"https:\/\/ibio.org\/wp-json\/wp\/v2\/comments?post=10061"}],"version-history":[{"count":1,"href":"https:\/\/ibio.org\/wp-json\/wp\/v2\/posts\/10061\/revisions"}],"predecessor-version":[{"id":10062,"href":"https:\/\/ibio.org\/wp-json\/wp\/v2\/posts\/10061\/revisions\/10062"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ibio.org\/wp-json\/wp\/v2\/media\/9943"}],"wp:attachment":[{"href":"https:\/\/ibio.org\/wp-json\/wp\/v2\/media?parent=10061"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ibio.org\/wp-json\/wp\/v2\/categories?post=10061"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ibio.org\/wp-json\/wp\/v2\/tags?post=10061"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}